Cromwell Holdings’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.5K Buy
485
+15
+3% +$3.11K 0.04% 366
2026
Q1
$106K Hold
470
0.06% 312
2025
Q4
$113K Hold
470
0.06% 285
2025
Q3
$129K Hold
470
0.07% 268
2025
Q2
$121K Buy
470
+13
+3% +$3.1K 0.07% 267
2025
Q1
$102K Buy
457
+7
+2% +$1.63K 0.07% 286
2024
Q4
$103K Hold
450
0.06% 282
2024
Q3
$110K Hold
450
0.07% 272
2024
Q2
$86.1K Buy
+450
New +$91.3K 0.05% 317

Other funds holding RMD

Cromwell Holdings's RMD Position: Q2 2026 in Review

Cromwell Holdings increased its ResMed (RMD) stake by 3.2% in Q2 2026, buying an estimated $3.11K and bringing the position to 485 shares worth $94.5K. The position accounts for 0.04% of the portfolio, ranked #366.

Cromwell Holdings first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $129K in Q3 2025. 142 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cromwell Holdings held 485 shares of ResMed worth $94.5K as of Q2 2026.
  • Cromwell Holdings bought 15 ResMed shares in Q2 2026, an estimated $3.11K.
  • ResMed made up 0.04% of Cromwell Holdings's portfolio in Q2 2026, its #366 holding.
  • Cromwell Holdings first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's ResMed position peaked at $129K in Q3 2025.
  • 142 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.